Cargando…
Tumour heterogeneity poses a significant challenge to cancer biomarker research
BACKGROUND: The high degree of genomic diversity in cancer represents a challenge for identifying objective prognostic markers. We aimed to examine the extent of tumour heterogeneity and its effect on the evaluation of a selected prognostic marker using prostate cancer as a model. METHODS: We assess...
Autores principales: | Cyll, Karolina, Ersvær, Elin, Vlatkovic, Ljiljana, Pradhan, Manohar, Kildal, Wanja, Avranden Kjær, Marte, Kleppe, Andreas, Hveem, Tarjei S, Carlsen, Birgitte, Gill, Silje, Löffeler, Sven, Haug, Erik Skaaheim, Wæhre, Håkon, Sooriakumaran, Prasanna, Danielsen, Håvard E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537489/ https://www.ncbi.nlm.nih.gov/pubmed/28618431 http://dx.doi.org/10.1038/bjc.2017.171 |
Ejemplares similares
-
Prognostic value of mitotic checkpoint protein BUB3, cyclin B1, and pituitary tumor-transforming 1 expression in prostate cancer
por: Ersvær, Elin, et al.
Publicado: (2019) -
Chromatin changes predict recurrence after radical prostatectomy
por: Hveem, Tarjei S, et al.
Publicado: (2016) -
PTEN and DNA Ploidy Status by Machine Learning in Prostate Cancer
por: Cyll, Karolina, et al.
Publicado: (2021) -
Cancer Prognosis Defined by the Combined Analysis of 8q, PTEN and ERG
por: Silva, Maria P., et al.
Publicado: (2016) -
Chromatin organisation and cancer prognosis: a pan-cancer study
por: Kleppe, Andreas, et al.
Publicado: (2018)